Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications

Int J Mol Sci. 2022 Oct 19;23(20):12526. doi: 10.3390/ijms232012526.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that has caused a 'coronavirus disease 2019' (COVID-19) pandemic in multiple waves, which threatens human health and public safety. During this pandemic, some patients with COVID-19 acquired secondary infections, such as mucormycosis, also known as black fungus disease. Mucormycosis is a serious, acute, and deadly fungal infection caused by Mucorales-related fungal species, and it spreads rapidly. Hence, prompt diagnosis and treatment are necessary to avoid high mortality and morbidity rates. Major risk factors for this disease include uncontrolled diabetes mellitus and immunosuppression that can also facilitate increases in mucormycosis infections. The extensive use of steroids to prevent the worsening of COVID-19 can lead to black fungus infection. Generally, antifungal agents dedicated to medical applications must be biocompatible, non-toxic, easily soluble, efficient, and hypoallergenic. They should also provide long-term protection against fungal growth. COVID-19-related black fungus infection causes a severe increase in fatalities. Therefore, there is a strong need for the development of novel and efficient antimicrobial agents. Recently, nanoparticle-containing products available in the market have been used as antimicrobial agents to prevent bacterial growth, but little is known about their efficacy with respect to preventing fungal growth, especially black fungus. The present review focuses on the effect of various types of metal nanoparticles, specifically those containing silver, zinc oxide, gold, copper, titanium, magnetic, iron, and carbon, on the growth of various types of fungi. We particularly focused on how these nanoparticles can impact the growth of black fungus. We also discussed black fungus co-infection in the context of the global COVID-19 outbreak, and management and guidelines to help control COVID-19-associated black fungus infection. Finally, this review aimed to elucidate the relationship between COVID-19 and mucormycosis.

Keywords: COVID-19; copper oxide nanoparticles; gold nanoparticles; magnetic and iron nanoparticles; mucormycosis; silver nanoparticles; zinc oxide nanoparticles.

Publication types

  • Review

MeSH terms

  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • COVID-19 Drug Treatment*
  • Carbon / pharmacology
  • Copper / pharmacology
  • Gold / pharmacology
  • Humans
  • Iron / pharmacology
  • Mucorales*
  • Mucormycosis* / drug therapy
  • Mucormycosis* / epidemiology
  • Mucormycosis* / microbiology
  • Nanoparticles*
  • SARS-CoV-2
  • Silver / pharmacology
  • Titanium / pharmacology
  • Zinc Oxide* / pharmacology

Substances

  • Antifungal Agents
  • Silver
  • Zinc Oxide
  • Copper
  • Titanium
  • Iron
  • Gold
  • Carbon

Grants and funding

This work was supported by “Basic Science Research Program (2021R1C1C100954611) of Korea National Research Foundation grant”.